Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of hypertension and genetic variants in MYH9 and BMPR1B with increased proteinuria in sickle cell disease. | Clin Biochem | 2026 | 41265744 | PubTator, text mining | PubMed |
| Re-evaluating the MYH9 p.I1816V variant in a patient with atypical clinical presentation. | Pediatr Nephrol | 2026 | 41243005 | PubTator, text mining | PubMed |
| Quantifying the Single-Cell Morphological Landscape of Cellular Transdifferentiation through Force Field Reconstruction. | Adv Sci (Weinh) | 2026 | 41203584 | PubTator, text mining | PubMed |
| m6A Modification-Mediated LINC01547 Promotes Pancreatic Cancer Growth and Gemcitabine Resistance Through miR-34a-5p/MYH9 Axis. | Biochem Genet | 2026 | 41046501 | PubTator, text mining | PubMed |
| Identification of potentially deleterious mutations in gastric cancer using patient-derived xenograft models. | Front Genet | 2025 | 41696640 | PubTator, text mining | PubMed |
| A plasma proteomic signature of the actin-coagulation axis accurately predicts progression to active tuberculosis. | Front Microbiol | 2025 | 41669692 | PubTator, text mining | PubMed |
| Genetic patterns & public health implications of sickle cell anaemia across populations: A systematic review. | Indian J Med Res | 2025 | 41520274 | PubTator, text mining | PubMed |
| Machine learning screening for disulfidptosis genes-associated immunosuppression status in osteosarcoma and rhabdomyosarcoma. | Transl Cancer Res | 2025 | 41510106 | PubTator, text mining | PubMed |
| Identification of coagulation-related hub genes in ischemic stroke based on bioinformatics integration analysis and investigation of their immune regulatory mechanisms. | Eur J Med Res | 2025 | 41444657 | PubTator, text mining | PubMed |
| Bioenergetic responses to β-adrenergic stimulation in beige adipocyte depend on actomyosin driven forces. | bioRxiv | 2025 | 41409152 | PubTator, text mining | PubMed |
| Correction for Jang et al., Lipid raft proteomics identify endothelial myosin-9 (MYH9) as a regulator of low-density lipoprotein transcytosis and atherosclerosis. | Proc Natl Acad Sci U S A | 2025 | 41370348 | PubTator, text mining | PubMed |
| Lactylation-driven KRT19 promotes non-small cell lung cancer progression by suppressing cellular senescence. | J Exp Clin Cancer Res | 2025 | 41345704 | PubTator, text mining | PubMed |
| Clinical and Molecular Spectrum of MYH9-Thrombocytopenia: Insights from a Single Centric Pediatric Cohort. | Children (Basel) | 2025 | 41300679 | PubTator, text mining | PubMed |
| Proteomics of Duchenne Muscular Dystrophy Patient iPSC-Derived Skeletal Muscle Cells Reveal Differential Expression of Cytoskeletal and Extracellular Matrix Proteins. | Cells | 2025 | 41227334 | PubTator, text mining | PubMed |
| Phospho-activated non-muscle myosin IIA heavy chain supports different mechanisms of virus uptake. | J Virol | 2025 | 41217108 | PubTator, text mining | PubMed |
| HydraRNA: a hybrid architecture based full-length RNA language model. | Genome Biol | 2025 | 41214747 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Identify FIGO Stage II Cervical Cancer Patients with a Higher Risk of Relapse in a Small Cohort. | J Pers Med | 2025 | 41149858 | PubTator, text mining | PubMed |
| Lipid raft proteomics identify endothelial myosin-9 (MYH9) as a regulator of low-density lipoprotein transcytosis and atherosclerosis. | Proc Natl Acad Sci U S A | 2025 | 41134623 | PubTator, text mining | PubMed |
| Myosin-9 is required for lysosome-mediated nonlytic reovirus egress. | PLoS Pathog | 2025 | 41086247 | PubTator, text mining | PubMed |
| Deciphering the landscape of post-translational modifications in the centrosome upon T cell activation. | Eur J Cell Biol | 2025 | 41046742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=6